Nitrosamines impurities carcinogenicity assessment - regulatory requirements, challenges and recommendations

被引:0
|
作者
Mishra, S. [1 ]
Autiero, M. [2 ]
Vishnoi, S. [1 ]
De Roy, C. [2 ]
Barai, N. [1 ]
Chakraborty, S. [2 ]
Tencalla, F. [2 ]
Petry, T. [2 ]
机构
[1] ToxMinds India Consulting Pvt Ltd, Brigade IRV, Regus Off, Bengaluru 560066, India
[2] ToxMinds BVBA, Ave Broqueville 116, B-1200 Brussels, Belgium
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
P24-41
引用
收藏
页码:S280 / S281
页数:2
相关论文
共 50 条
  • [1] N-Nitrosamines Impurities in Pharmaceuticals The Abrupt Challenges that Resulted, the Evolving Science, and the Regulatory Framework
    Moser, Justin
    Schlingemann, Jorg
    Saal, Christoph
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (05) : 1161 - 1162
  • [2] Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals
    Contrera, JF
    Jacobs, AC
    DeGeorge, JJ
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 25 (02) : 130 - 145
  • [3] Carcinogenicity assessment: technical and political challenges
    Madia, F.
    Worth, A.
    Whelan, M.
    Corvi, R.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30
  • [4] Regulatory Requirements for Genotoxicity Assessment of Plant Protection Product Active Ingredients, Impurities, and Metabolites
    Booth, Ewan D.
    Rawlinson, Paul J.
    Fagundes, Priscila Maria
    Leiner, Kevin A.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2017, 58 (05) : 325 - 344
  • [5] NITROSAMINES IN FOOD-CONTACT NETTING - REGULATORY AND ANALYTICAL CHALLENGES
    MARSDEN, J
    PESSELMAN, R
    FOOD TECHNOLOGY, 1993, 47 (03) : 131 - 134
  • [6] An overview of radiation safety regulatory recommendations and requirements
    Balter, S
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 1999, 47 (04) : 469 - 474
  • [7] Recommendations on the Internet of Things: Requirements, Challenges, and Directions
    Yao, Lina
    Wang, Xianzhi
    Sheng, Quan Z.
    Dustdar, Schahram
    Zhang, Shuai
    IEEE INTERNET COMPUTING, 2019, 23 (03) : 46 - 54
  • [8] Alternative test methods for (nano)materials hazards assessment: Challenges and recommendations for regulatory preparedness
    Gomes, Susana I. L.
    Scott-Fordsmand, Janeck J.
    Amorim, Monica J. B.
    NANO TODAY, 2021, 40
  • [9] Controlling of genotoxic impurities in pharmaceuticals: International harmonisation of regulatory requirements
    Kasper, P.
    TOXICOLOGY LETTERS, 2011, 205 : S7 - S7
  • [10] N-Nitrosamines Impurities in Pharmaceuticals the Abrupt Challenges They Bring and Approaches to Tackle the Risk
    Moser, Justin
    Keire, David
    Schlingemann, Joerg
    Saal, Christoph
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 111 (10) : 2651 - 2651